Women’s Health Strategy: Time to have women’s voices at the top of the agenda

https://www.gov.uk/government/consultations/womens-health-strategy-call-for-evidence/womens-health-strategy-call-for-evidence.

Hamoda H Panay N Pedder H , et al. The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reprod Health. 2020;26(4):181–209. doi:10.1177/2053369120957514

Avis NE Crawford SL Greendale G , et al.(2015) Duration of menopausal vasomotor symptoms over the menopause transition. JAMA: J Am Med Assoc 175(4), 531–539.

National Institute for Health and Care Excellence . Menopause: Clinical Guideline – Methods, Evidence and Recommendations, (NG23), Version 1.5. https://www.nice.org.uk/guidance/ng23/evidence/fullguideline-559549261 (accessed 9 October 2021).

British Menopause Society Council . Modernizing the NHS: observations and recommendations from the British Menopause Society. Menopause Int. 2011;17(2):41–43. doi:10.1258/mi.2011.011015

Currie H Abernethy K Hamoda H . Vision for menopause care in the UK. Post Reprod Health. 2021;27(1):10–18. doi:10.1177/2053369121989230